1
|
Segura-García S, Barrera-Ramírez A, Gutiérrez-Esparza GO, Groves-Miralrio E, Martínez-García M, Hernández-Lemus E. Effects of social confinement during the first wave of COVID-19 in Mexico City. Front Public Health 2023; 11:1202202. [PMID: 37427289 PMCID: PMC10326270 DOI: 10.3389/fpubh.2023.1202202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Accepted: 05/31/2023] [Indexed: 07/11/2023] Open
Abstract
Background The COVID-19 pandemic led to global social confinement that had a significant impact on people's lives. This includes changes such as increased loneliness and isolation, changes in sleep patterns and social habits, increased substance use and domestic violence, and decreased physical activities. In some cases, it has increased mental health problems, such as anxiety, depression, and post-traumatic stress disorder. Objective The objective of this study is to analyze the living conditions that arose during social confinement in the first wave of COVID-19 within a group of volunteers in Mexico City. Methods This is a descriptive and cross-sectional analysis of the experiences of volunteers during social confinement from 20 March 2020 to 20 December 2020. The study analyzes the impact of confinement on family life, work, mental health, physical activity, social life, and domestic violence. A maximum likelihood generalized linear model is used to determine the association between domestic violence and demographic and health-related factors. Results The findings indicate that social confinement had a significant impact on the participants, resulting in difficulties within families and vulnerable conditions for individuals. Gender and social level differences were observed in work and mental health. Physical activity and social life were also modified. We found that suffering from domestic violence was significantly associated with being unmarried (OR = 1.4454, p-value = 0.0479), lack of self-care in feeding habits (OR = 2.3159, p-value = 0.0084), and most notably, having suffered from a symptomatic COVID-19 infection (OR = 4.0099, p-value = 0.0009). Despite public policy to support vulnerable populations during confinement, only a small proportion of the studied population reported benefiting from it, suggesting areas for improvement in policy. Conclusion The findings of this study suggest that social confinement during the COVID-19 pandemic had a significant impact on the living conditions of people in Mexico City. Modified circumstances on families and individuals, included increased domestic violence. The results can inform policy decisions to improve the living conditions of vulnerable populations during times of social confinement.
Collapse
Affiliation(s)
- Stephany Segura-García
- Health Promotion Program, Universidad Autónoma de la Ciudad de México, Mexico City, Mexico
| | | | | | | | - Mireya Martínez-García
- Department of Immunology, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico
| | - Enrique Hernández-Lemus
- Computational Genomics Division, National Institute of Genomic Medicine, Mexico City, Mexico
- Center for Complexity Sciences, Universidad Nacional Autónoma de México, Mexico City, Mexico
| |
Collapse
|
2
|
Saucedo-Uribe E, Treviño-Lozano J, González-Mallozzi PJ, Enríquez-Navarro MK, de la Cruz-de la Cruz C, Rangel-Gómez AN, Carranza-Navarro F, Pardiñaz-García DD, Fuentes-Garza JM. Anxiety in Mexican adults throughout the COVID-19 pandemic: A cross sectional study. Arch Psychiatr Nurs 2022; 41:201-207. [PMID: 36428050 PMCID: PMC9422398 DOI: 10.1016/j.apnu.2022.08.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2022] [Revised: 08/11/2022] [Accepted: 08/21/2022] [Indexed: 12/14/2022]
Abstract
INTRODUCTION Perceived fear during a pandemic along with measures used to contain it can develop or intensify anxiety symptoms. In Mexico, information on the psychological impact of the COVID-19 pandemic in the general population is scarce. OBJECTIVE We examined the prevalence and factors associated with anxiety during the COVID-19 outbreak in a Mexican sample. METHOD We conducted a cross sectional study from June 15, 2020, to January 31, 2021, in a state in north-eastern Mexico, using an online survey. Beck Anxiety Inventory was used to determine the prevalence and severity of anxiety. RESULTS The overall prevalence of anxiety was 43.5 %. Categories with the highest anxiety prevalence within their groups were women (46.2 %), age group of 18-30 years (47.3 %), higher level of education (43 %), students (48.8 %) and people who weren't currently with a couple (47.3 %). Additionally, we found that people who reported clinically significant anxiety were more likely to be women, ages 18-30 years, not currently partnered and currently living with a psychiatric disorder. Moreover, patients with clinically significant anxiety were more likely to be diagnosed with a mood, anxiety, trauma and stress, or an eating disorder. We also observed that being a woman and having at least one psychiatric disorder were independent factors related to a positive anxiety screening. DISCUSSION AND CONCLUSION COVID-19 outbreak results in considerable increase in anxiety symptoms among the Mexican population. It is important to acknowledge the psychological impact of contingency situations to provide information that can allow establishing preventive and therapeutic strategies.
Collapse
Affiliation(s)
- Erasmo Saucedo-Uribe
- Department of Psychiatry, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico; Advanced Neuroscience Center UANL, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico.
| | - Jessica Treviño-Lozano
- Department of Psychiatry, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico
| | - Pedro Jehú González-Mallozzi
- Advanced Neuroscience Center UANL, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico
| | - Moisés Karika Enríquez-Navarro
- Advanced Neuroscience Center UANL, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico
| | - Carlos de la Cruz-de la Cruz
- Faculty of Medicine, Universidad Autónoma de Nuevo León, Madero y Dr. Aguirre Pequeño n/n, Mitras Centro P.C 64460, Monterrey, Nuevo León, Mexico
| | - Ada Nayeli Rangel-Gómez
- Advanced Neuroscience Center UANL, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico
| | - Farid Carranza-Navarro
- Advanced Neuroscience Center UANL, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero n/n. & Av. Gonzalitos, Mitras Centro P.C. 64460, Monterrey, Nuevo León, Mexico
| | - Dania Dalel Pardiñaz-García
- Faculty of Medicine, Universidad Autónoma de Nuevo León, Madero y Dr. Aguirre Pequeño n/n, Mitras Centro P.C 64460, Monterrey, Nuevo León, Mexico
| | - Juan Manuel Fuentes-Garza
- Faculty of Medicine, Universidad Autónoma de Nuevo León, Madero y Dr. Aguirre Pequeño n/n, Mitras Centro P.C 64460, Monterrey, Nuevo León, Mexico
| |
Collapse
|
3
|
Muñiz-Salazar R, Le T, Cuevas-Mota J, González-Fagoaga JE, Zapata-Garibay R, Ruiz-Tamayo PS, Robles-Flores J, Garfein RS. Impact of COVID-19 on tuberculosis detection and treatment in Baja California, México. Front Public Health 2022; 10:921596. [PMID: 35942259 PMCID: PMC9356343 DOI: 10.3389/fpubh.2022.921596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2022] [Accepted: 07/05/2022] [Indexed: 11/13/2022] Open
Abstract
In 2020, Mexico reported the lowest tuberculosis (TB) incidence on record, and it is unclear to what extent COVID-19 has impacted TB surveillance, diagnosis, and treatment. It is important to understand COVID-19's impact in Baja California (BC), which has the highest TB burden in Mexico. With the increasing number of migrants and asylum seekers arriving in BC, limited resources and crowded living conditions increase the risk of TB transmission. The purpose of this study was to assess the impact of COVID-19 on TB diagnosis and treatment in BC. We were also interested in health disparities experienced by migrants in BC. We conducted a mixed methods analysis using quantitative surveillance data obtained from the Mexico National TB Program (NTP) and qualitative data collected through in-depth interviews and focus group discussions with TB program directors and personnel in BC's four provincial health jurisdictions. Compared to the year prior, surveillance data from March 2020 - February 2021 revealed that TB incidence in BC declined by 30.9% and favorable TB outcomes (TB cure or treatment completion) declined by 49.8%. Elucidating differences by migrant status was complicated by the lack of standardized collection of migrant status by the NTP. Qualitative analysis revealed that TB diagnostic and treatment supplies and services became limited and disproportionately accessible across jurisdictions since the pandemic began; however, favorable adaptations were also reported, such as increased telemedicine use and streamlined care referral processes. Participants shared that migrant status is susceptible to misclassification and that TB care is difficult due to the transitory nature of migrants. This study did not identify major differences in TB service delivery or access between migrants and non-migrants in BC; however, migrant status was frequently missing. COVID-19 has overwhelmed health systems worldwide, disrupting timely TB diagnostic and treatment services, and potentially caused underdiagnosis of TB in BC. TB programs in BC should quickly restore essential services that were disrupted by COVID-19 while identifying and preserving beneficial program adaptations, such as telemedicine and streamlined care referral processes. Improved methods for documenting migrant status of TB cases are also needed.
Collapse
Affiliation(s)
- Raquel Muñiz-Salazar
- Escuela de Ciencias de la Salud, Universidad Autónoma de Baja California, Ensenada, Mexico
- *Correspondence: Raquel Muñiz-Salazar
| | - Tina Le
- Herbert Wertheim School of Public Health, University of California, San Diego, San Diego, CA, United States
| | - Jazmine Cuevas-Mota
- Herbert Wertheim School of Public Health, University of California, San Diego, San Diego, CA, United States
| | - Jesús Eduardo González-Fagoaga
- Healthy Border Program, US-Mexico Border Heath Commission, Tijuana, Mexico
- Facultad de Humanidades y Ciencias Sociales, Universidad Autónoma de Baja California, Tijuana, Mexico
| | - Rogelio Zapata-Garibay
- Healthy Border Program, US-Mexico Border Heath Commission, Tijuana, Mexico
- Facultad de Humanidades y Ciencias Sociales, Universidad Autónoma de Baja California, Tijuana, Mexico
| | | | - Javier Robles-Flores
- Escuela de Ciencias de la Salud, Universidad Autónoma de Baja California, Ensenada, Mexico
| | - Richard S. Garfein
- Herbert Wertheim School of Public Health, University of California, San Diego, San Diego, CA, United States
| |
Collapse
|
4
|
Filosa JN, Botello-Mares A, Goodman-Meza D. COVID-19 needs no passport: the interrelationship of the COVID-19 pandemic along the U.S.-Mexico border. BMC Public Health 2022; 22:1081. [PMID: 35641957 PMCID: PMC9153860 DOI: 10.1186/s12889-022-13513-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 05/25/2022] [Indexed: 01/11/2023] Open
Abstract
OBJECTIVES To investigate the impact of the COVID-19 pandemic along the U.S.-Mexico border region and evaluate the relationship of COVID-19 related mortality, socioeconomic status, and vaccination. METHODS We used indirect standardization to age-adjust mortality rates and calculate standardized mortality ratios [SMR] in both countries. To examine the impact of socioeconomic factors, we calculated the Human Development Index (HDI) by county/municipality. We performed linear regression to understand the relationship between mortality, vaccination, and HDI. We used choropleth maps to visualize the trends seen in the region. RESULTS Between January 22nd, 2020 and December 1st, 2021, surges of cases and deaths were similar in dyad cities along the U.S.-Mexico border visualizing the interconnectedness of the region. Mortality was higher in U.S. counties along the border compared to the national average (SMR 1.17, 95% CI 1.15-1.19). In Mexico, border counties had a slightly lower mortality to the national average (SMR 0.94, 95% CI 0.93-0.95). In U.S. border states, SMR was shown to negatively correlate with human development index (HDI), a socioeconomic proxy, resulting in a higher SMR in the border region compared to the rest of the counties. Conversely in Mexican border states, there was no association between SMR and HDI. Related to vaccination, U.S. counties along the border were vaccinated at a greater percentage than non-border counties and vaccination was negatively correlated with HDI. In Mexico, states along the border had a higher ratio of vaccinations per person than non-border states. CONCLUSIONS The U.S.-Mexico border is a divide of incredible importance not only to immigration but as a region with unique social, economic, environmental, and epidemiological factors that impact disease transmission. We investigated how the COVID-19 pandemic followed trends of previously studied diseases in the corridor such as tuberculosis, HIV, and influenza H1N1. These data state how targeted intervention along the U.S.-Mexico border region is a necessity when confronting COVID-19 and have implications for future control of infectious diseases in the region.
Collapse
Affiliation(s)
- John N Filosa
- David Geffen School of Medicine, University of California, Los Angeles (UCLA), 10833 Le Conte Ave, Los Angeles, CA, 90095-1688, USA
| | - Adrian Botello-Mares
- Department of Population Studies, Colegio de la Frontera Norte, Sonora, Nogales, Mexico
| | - David Goodman-Meza
- David Geffen School of Medicine, University of California, Los Angeles (UCLA), 10833 Le Conte Ave, Los Angeles, CA, 90095-1688, USA.
- Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles (UCLA), CA, Los Angeles, USA.
| |
Collapse
|
5
|
Márquez-González H, Méndez-Galván JF, Reyes-López A, Klünder-Klünder M, Jiménez-Juárez R, Garduño-Espinosa J, Solórzano-Santos F. Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors. Front Public Health 2021; 9:660114. [PMID: 34386471 PMCID: PMC8353107 DOI: 10.3389/fpubh.2021.660114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Accepted: 06/24/2021] [Indexed: 12/15/2022] Open
Abstract
The pandemic caused by the new coronavirus Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries. The most lethal clinical presentation is respiratory insufficiency, requiring attention in intensive care units (ICU). The most susceptible people are over 60 years old with comorbidities. The health systems organization may represent a transcendental role in survival. Objective: To analyze the correlation of sociodemographic factors, comorbidities and health system organization variables with survival in cases infected by SARS-CoV-2 during the first 7 months of the pandemic in Mexico. Methods: The cohort study was performed in a health system public basis from March 1st to September 30th, 2020. The included subjects were positive for the SARS-CoV-2 test, and the target variable was mortality in 60 days. The risk variables studied were: age, sex, geographic distribution, comorbidities, health system, hospitalization, and access to ICU. Bivariate statistics (X2-test), calculation of fatality rates, survival analyses and adjustment of confusing variables with Cox proportional-hazards were performed. Results: A total of 753,090 subjects were analyzed, of which the 52% were men. There were 78,492 deaths (10.3% of general fatality and 43% inpatient). The variables associated with a higher risk of hospital mortality were age (from 60 years onwards), care in public sectors, geographic areas with higher numbers of infection and endotracheal intubation without management in the ICU. Conclusions: The variables associated with a lower survival in cases affected by SARS-CoV-2 were age, comorbidities, and respiratory insufficiency (with endotracheal intubation without care in the ICU). Additionally, an interaction was observed between the geographic location and health sector where they were treated.
Collapse
Affiliation(s)
- Horacio Márquez-González
- Department of Clinical Research, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | - Jorge F. Méndez-Galván
- Centre for Research in Emerging Diseases, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | - Alfonso Reyes-López
- Centre for Health Economics, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | | | - Rodolfo Jiménez-Juárez
- Clinical Infectious Disease Department, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | - Juan Garduño-Espinosa
- Clinical Research Direction, Hospital Infantil de México Federico Gómez, Mexico City, Mexico
| | - Fortino Solórzano-Santos
- Infectious Diseases Research Department, Hospital Infantil de México Federico GómezMéxico Federico Gómez, Mexico City, Mexico
| |
Collapse
|
6
|
Fernández-Rojas MA, Luna-Ruiz Esparza MA, Campos-Romero A, Calva-Espinosa DY, Moreno-Camacho JL, Langle-Martínez AP, García-Gil A, Solís-González CJ, Canizalez-Román A, León-Sicairos N, Alcántar-Fernández J. Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people. Int J Infect Dis 2021; 104:572-579. [PMID: 33434668 PMCID: PMC7831729 DOI: 10.1016/j.ijid.2020.12.086] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 12/28/2020] [Accepted: 12/31/2020] [Indexed: 01/01/2023] Open
Abstract
OBJECTIVES The COVID-19 diagnosis is difficult and ambiguous due to nonspecific symptoms. Further, data from Mexico arehospitable population-based without signs and symptoms information. Thus, this work aims to provide epidemiology information about the burden of COVID-19 in Mexican outpatients and to identify symptomatic COVID-19 profiles that could help in the early diagnosis of the disease. METHODS From June to September, epidemiological, clinical, and demographic data of 482,413 individuals diagnosed by RT-PCR test for SARS-CoV-2 in Salud Digna clinics were collected. RESULTS We observed a 41% incidence of SARS-CoV-2 infections with a mean age of 36 years and with young adults (20-40 years) being the most affected. Among occupations, delivery persons (OR 1.38) or informal traders (OR 1.33) had a higher risk of COVID-19. Moreover, 13% of SARS-CoV-2 infections were in presymptomatic patients. Finally, we identified three different symptomatic profiles (common, respiratory, and gastrointestinal) associated with COVID-19. CONCLUSION The incidence of SARS-CoV-2 was high among outpatients with a significant proportion of presymptomatic carriers, and thus it is necessary to increase testing and continue SARS-CoV-2 surveillance with a better description of signs and symptoms; in this regard, we identified three symptomatic profiles that could help in the diagnosis of COVID-19.
Collapse
Affiliation(s)
| | | | | | | | - José L Moreno-Camacho
- Clinical Laboratory Division, Salud Digna, Culiacan, 80000, Sinaloa, Mexico; Molecular Biology Laboratory, National Reference Center, Salud Digna, La Primavera, Culiacan, 80199, Sinaloa, Mexico
| | - Ariadna P Langle-Martínez
- Clinical Laboratory Division, Salud Digna, Culiacan, 80000, Sinaloa, Mexico; Molecular Biology Laboratory, National Reference Center "Mexico's Valley", Salud Digna, Los Reyes, Tlalnepantla de Baz, 54075, Estado de Mexico, Mexico
| | - Abraham García-Gil
- Clinical Laboratory Division, Salud Digna, Culiacan, 80000, Sinaloa, Mexico; Molecular Biology Laboratory, National Reference Center, Salud Digna, La Primavera, Culiacan, 80199, Sinaloa, Mexico
| | - Claudia J Solís-González
- Clinical Laboratory Division, Salud Digna, Culiacan, 80000, Sinaloa, Mexico; Molecular Biology Laboratory, National Reference Center "Mexico's Valley", Salud Digna, Los Reyes, Tlalnepantla de Baz, 54075, Estado de Mexico, Mexico
| | - Adrián Canizalez-Román
- CIASaP, School of Medicine, Autonomous University of Sinaloa, 80246 Culiacan, Sinaloa, Mexico; The Women's Hospital, Secretariat of Health, 80127 Culiacan, Mexico
| | - Nidia León-Sicairos
- CIASaP, School of Medicine, Autonomous University of Sinaloa, 80246 Culiacan, Sinaloa, Mexico; Pediatric Hospital of Sinaloa, 80200 Culiacan, Sinaloa, Mexico
| | | |
Collapse
|
7
|
Rizo-Téllez SA, Méndez-García LA, Flores-Rebollo C, Alba-Flores F, Alcántara-Suárez R, Manjarrez-Reyna AN, Baltazar-López N, Hernández-Guzmán VA, León-Pedroza JI, Zapata-Arenas R, González-Chávez A, Hernández-Ruíz J, Carrillo-Ruíz JD, Serrano-Loyola R, Guerrero-Avendaño GML, Escobedo G. The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19). Microorganisms 2020; 8:E1560. [PMID: 33050487 PMCID: PMC7600553 DOI: 10.3390/microorganisms8101560] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Revised: 10/02/2020] [Accepted: 10/07/2020] [Indexed: 12/16/2022] Open
Abstract
There is a deep need for mortality predictors that allow clinicians to quickly triage patients with severe coronavirus disease 2019 (Covid-19) into intensive care units at the time of hospital admission. Thus, we examined the efficacy of the lymphocyte-to-neutrophil ratio (LNR) and neutrophil-to-monocyte ratio (NMR) as predictors of in-hospital death at admission in patients with severe Covid-19. A total of 54 Mexican adult patients with Covid-19 that met hospitalization criteria were retrospectively enrolled, followed-up daily until hospital discharge or death, and then assigned to survival or non-survival groups. Clinical, demographic, and laboratory parameters were recorded at admission. A total of 20 patients with severe Covid-19 died, and 75% of them were men older than 62.90 ± 14.18 years on average. Type 2 diabetes, hypertension, and coronary heart disease were more prevalent in non-survivors. As compared to survivors, LNR was significantly fourfold decreased while NMR was twofold increased. LNR ≤ 0.088 predicted in-hospital mortality with a sensitivity of 85.00% and a specificity of 74.19%. NMR ≥ 17.75 was a better independent risk factor for mortality with a sensitivity of 89.47% and a specificity of 80.00%. This study demonstrates for the first time that NMR and LNR are accurate predictors of in-hospital mortality at admission in patients with severe Covid-19.
Collapse
Affiliation(s)
- Salma A. Rizo-Téllez
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
- PECEM, Facultad de Medicina, Universidad Nacional Autónoma de México, Coyoacán, Mexico City 04510, Mexico
| | - Lucia A. Méndez-García
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
| | - Cruz Flores-Rebollo
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
- Research Coordination at Central Laboratories, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (N.B.-L.); (V.A.H.-G.)
| | - Fernando Alba-Flores
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
| | - Raúl Alcántara-Suárez
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
| | - Aarón N. Manjarrez-Reyna
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
| | - Neyla Baltazar-López
- Research Coordination at Central Laboratories, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (N.B.-L.); (V.A.H.-G.)
| | - Verónica A. Hernández-Guzmán
- Research Coordination at Central Laboratories, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (N.B.-L.); (V.A.H.-G.)
| | - José I. León-Pedroza
- Department of Intensive Medical Therapy, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico;
| | - Rogelio Zapata-Arenas
- Department of Internal Medicine, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (R.Z.-A.); (A.G.-C.)
| | - Antonio González-Chávez
- Department of Internal Medicine, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (R.Z.-A.); (A.G.-C.)
| | - Joselín Hernández-Ruíz
- Clinical Pharmacology Unit, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico;
| | - José D. Carrillo-Ruíz
- Department of Neurology and Neurosurgery, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico;
| | - Raúl Serrano-Loyola
- Department of Radiology and Imaging, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (R.S.-L.); (G.M.L.G.-A.)
| | - Guadalupe M. L. Guerrero-Avendaño
- Department of Radiology and Imaging, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (R.S.-L.); (G.M.L.G.-A.)
| | - Galileo Escobedo
- Laboratory of Immunometabolism, Research Division, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City 06720, Mexico; (S.A.R.-T.); (L.A.M.-G.); (C.F.-R.); (F.A.-F.); (R.A.-S.); (A.N.M.-R.)
| |
Collapse
|
8
|
Affiliation(s)
- Ariel Pablos-Méndez
- Division of General Medicine, Columbia University Medical Center, New York, USA
| | | | | | | | - Mario C Raviglione
- Centre for Multidisciplinary Research in Health Science (MACH). University of Milan, Italy
| |
Collapse
|